Dassault White Papers
-
Importance Of Integrated Informatics For Life Science Organizations
4/21/2021
To satisfy the requirement of drug development companies for efficient data and tech transfer, standardization of data and technology transfer across the entire pharma product lifecycle is needed.
-
Accelerate Time To Market With An Electronic Lab Notebook
4/21/2021
Research organizations are challenged as never before to conceive and develop innovative scientific solutions rapidly and efficiently. Technology has made immense amounts of research information available at a keystroke—information that can spark creativity and new collaboration opportunities. However, scientists recording, managing and archiving research data in paper lab notebooks cannot keep up with this data deluge. This white paper examines the challenges of managing research data today and what to look for in an ELN.
-
Cloud-Based Research Informatics - Improve Collaboration, Agility And TCO Across Different Industries
4/1/2021
With cloud adoption significantly enhancing collaborative projects, increasing operational agility and lowering total cost of ownership (TCO), cloud computing has become a valuable and viable solution today; however, organizations are often uncertain about the best way to evaluate, select and implement a cloud collaboration platform. This paper will discuss the challenges of internal and external collaboration and how scientific research organizations can manage the transition to a more highly performant, flexible and agile partner workspace in the cloud with the help of a qualified cloud provider.
-
Industry Best Practices For Novel Biotherapeutic Entities
10/14/2020
As this next wave of antibody-based therapies gains momentum, biochemists have begun to create even more innovative molecules with additional modes of action including multispecific antibodies and other so-called Frankenmolecules. However, informatics technologies have not kept pace with these scientific innovations. It’s unlikely that any single life science company, technology vendor or academic group will be able to solve these issues unaided. But together we can establish systems and processes that make working with these new entities more efficient.
-
How Can We Predict Immunogenicity Earlier?
10/12/2020
With many biotherapeutics a strong immunogenic response can limit the effectiveness of the treatment or cause a more serious illness. This remains a challenge for scientists as the underlying mechanisms of unwanted immunogenicity still aren’t completely understood. Detecting and preventing unwanted sources of immunogenicity as early in the discovery process as possible has become a top priority for research organizations since biotherapeutic development becomes increasingly costly as it moves downstream.